These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3092270)

  • 1. The effect of experimentally-induced renal failure on accumulation of bupropion and its major basic metabolites in plasma and brain of guinea pigs.
    DeVane CL; Laizure SC; Cameron DF
    Psychopharmacology (Berl); 1986; 89(4):404-8. PubMed ID: 3092270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs.
    Suckow RF; Smith TM; Perumal AS; Cooper TB
    Drug Metab Dispos; 1986; 14(6):692-7. PubMed ID: 2877828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of bupropion and its major metabolites in human plasma.
    Laizure SC; DeVane CL
    Ther Drug Monit; 1985; 7(4):447-50. PubMed ID: 3936237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose.
    Laizure SC; DeVane CL; Stewart JT; Dommisse CS; Lai AA
    Clin Pharmacol Ther; 1985 Nov; 38(5):586-9. PubMed ID: 3931955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy Has No Clinically Significant Effect on the Pharmacokinetics of Bupropion or Its Metabolites.
    Fay EE; Czuba LC; Sager JE; Shum S; Stephenson-Famy A; Isoherranen N
    Ther Drug Monit; 2021 Dec; 43(6):780-788. PubMed ID: 33814540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion in depression. II. The role of metabolites in clinical outcome.
    Golden RN; De Vane CL; Laizure SC; Rudorfer MV; Sherer MA; Potter WZ
    Arch Gen Psychiatry; 1988 Feb; 45(2):145-9. PubMed ID: 3122699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of bupropion and its metabolites in haemodialysis patients who smoke. A single dose study.
    Worrall SP; Almond MK; Dhillon S
    Nephron Clin Pract; 2004; 97(3):c83-9. PubMed ID: 15292684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple doses.
    Posner J; Bye A; Dean K; Peck AW; Whiteman PD
    Eur J Clin Pharmacol; 1985; 29(1):97-103. PubMed ID: 3932079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual-wavelength ultraviolet detection.
    Cooper TB; Suckow RF; Glassman A
    J Pharm Sci; 1984 Aug; 73(8):1104-7. PubMed ID: 6436464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant profile of bupropion and three metabolites in mice.
    Martin P; Massol J; Colin JN; Lacomblez L; Puech AJ
    Pharmacopsychiatry; 1990 Jul; 23(4):187-94. PubMed ID: 2116631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of an unusual, but clinically significant, digoxin-bupropion drug interaction.
    He J; Yu Y; Prasad B; Chen X; Unadkat JD
    Biopharm Drug Dispos; 2014 Jul; 35(5):253-63. PubMed ID: 24436229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological significance of the species differences in bupropion metabolism.
    Welch RM; Lai AA; Schroeder DH
    Xenobiotica; 1987 Mar; 17(3):287-98. PubMed ID: 3107223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.
    O'Byrne PM; Williams R; Walsh JJ; Gilmer JF
    Pharmaceuticals (Basel); 2014 May; 7(6):676-94. PubMed ID: 24878537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.
    Drayer DE
    Clin Pharmacokinet; 1976; 1(6):426-43. PubMed ID: 799549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and kinetics of bupropion.
    Schroeder DH
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):79-81. PubMed ID: 6406469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacologic basis for therapeutic interest in bupropion.
    Soroko FE; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):67-73. PubMed ID: 6406467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay and pharmacokinetic profile of bupropion in the dog.
    Butz RF; Schroeder DH; Welch RM; Mehta NB; Phillips AP; Findlay JW
    J Pharmacol Exp Ther; 1981 Jun; 217(3):602-10. PubMed ID: 6785419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down regulation of beta-receptors by bupropion and its major metabolite in mouse brain.
    Perumal AS; Smith TM; Suckow RF; Cooper TB
    Neuropharmacology; 1986 Dec; 25(12):1323-6. PubMed ID: 3031529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine.
    Perumal AS; Smith TM; Suckow RF; Cooper TB
    Neuropharmacology; 1986 Feb; 25(2):199-202. PubMed ID: 3084990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease.
    DeVane CL; Laizure SC; Stewart JT; Kolts BE; Ryerson EG; Miller RL; Lai AA
    J Clin Psychopharmacol; 1990 Oct; 10(5):328-32. PubMed ID: 2124217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.